METAVENTION

metavention-logo

Metavention develops medical devices to help with interventional therapies for Type 2 diabetes.

#People #Financial #Website #More

METAVENTION

Social Links:

Industry:
Biotechnology Diabetes Health Care

Founded:
2012-01-01

Address:
Eden Prairie, Minnesota, United States

Country:
United States

Website Url:
http://www.metavention.com

Total Employee:
11+

Status:
Active

Contact:
16128148202

Email Addresses:
[email protected]

Total Funding:
65 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Apache Global Site Tag



Current Advisors List

kevin-hykes_image

Kevin Hykes Independent Director @ Metavention
Board_member
2017-08-01

kirk-g-nielsen_image

Kirk G. Nielsen Board Member @ Metavention
Board_member

Current Employees Featured

scott-vafai_image

Scott Vafai
Scott Vafai Co-Founder @ Metavention
Co-Founder
2012-01-01

todd-berg_image

Todd Berg
Todd Berg Chief Executive Officer @ Metavention
Chief Executive Officer
2018-01-01

not_available_image

Kavitha Ganesan
Kavitha Ganesan Director of Regulatory and Advanced Therapies @ Metavention
Director of Regulatory and Advanced Therapies
2019-08-01

Founder


bobak-azamian_image

Bobak Azamian

scott-vafai_image

Scott Vafai

Investors List

horowitz-group_image

Horowitz Group

Horowitz Group investment in Series C - Metavention

sanderling-ventures_image

Sanderling Ventures

Sanderling Ventures investment in Series C - Metavention

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series C - Metavention

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series C - Metavention

rk-mellon_image

RK Mellon

RK Mellon investment in Series C - Metavention

Official Site Inspections

http://www.metavention.com Semrush global rank: 8.16 M Semrush visits lastest month: 359

  • Host name: 240.112.180.107.host.secureserver.net
  • IP address: 107.180.112.240
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Metavention"

Homepage - Metavention

Metavention is a dedicated team with a proven track record of delivering innovative, life-changing therapies to patients and healthcare providers around the world. Everything we do is based on our fundamental beliefโ€”do what is โ€ฆSee details»

Company - Metavention

Our company is committed to challenging the status quo to deliver better treatment options to the millions of people who need them. Together, with patients and the healthcare professionals โ€ฆSee details»

Metavention, Inc. - LinkedIn

Metavention, Inc. | 892 followers on LinkedIn. Together, we can effect real change in the treatment of metabolic disease. | Headquartered in Minneapolis, Minnesota, Metavention, Inc. is a...See details»

Clinical Studies - Metavention

Metavention is conducting clinical studies for patients with high blood pressure. If you or someone you care about is interested in pursuing an alternative to current treatments, answer the questions below and click on Am I A Candidate to take โ€ฆSee details»

Metavention - Crunchbase Company Profile & Funding

Metavention develops medical devices to help with interventional therapies for high blood pressure and other metabolic diseases. View contacts for Metavention to access new leads โ€ฆSee details»

Metavention Company Profile 2024: Valuation, Funding

Metavention was founded in 2012. Where is Metavention headquartered? Metavention is headquartered in Maple Grove, MN. What is the size of Metavention? Metavention has 18 total โ€ฆSee details»

Metavention - The Org

Metavention is a privately held medical device company developing novel treatments for metabolic diseases.See details»

Metavention Announces Initiation of U.S. Clinical Trial for Novel ...

MINNEAPOLIS, Feb. 17, 2021 /PRNewswire/ -- Metavention, Inc. announces the initiation of an FDA-approved clinical investigation, DeLIVER (NCT04285554), for the Company's โ€ฆSee details»

Metavention - Products, Competitors, Financials, Employees ...

Metavention is a medical device company focused on developing treatments for metabolic diseases. The company's main offering is a minimally invasive procedure using the iRF โ€ฆSee details»

Metavention - Versant Ventures

Metavention seeks to develop a safe and effective treatment that can aid patients with type 2 diabetes who are struggling to control their blood sugar with lifestyle modification and non โ€ฆSee details»

Focus - Metavention

Innovative solutions to big challenges. The sympathetic nervous system plays an important role in regulating our metabolism by delivering information between our brain and the organs that control daily changes in our bodyโ€™s energy needs.See details»

Metavention Company Profile - Office Locations, Competitors

Metavention is a medical device company developing treatments for metabolic diseases. It provides a glucose control therapy for patients with type 2 diabetes. Metavention has 5 โ€ฆSee details»

Metavention Announces Initiation of Groundbreaking Multi-Organ ...

MINNEAPOLIS, May 3, 2021 /PRNewswire/ -- Metavention, Inc. announces the initiation of the MODUS Study (ACTRN12620000412932), to treat patients with both type 2 diabetes and โ€ฆSee details»

Metavention Completes U.S. Enrollment in ... - Markets Insider

Jan 5, 2022ย ยท Metavention, Inc. is a privately held medical device company headquartered in Maple Grove, Minnesota, and the developer of the iRF Denervation System. Metavention's โ€ฆSee details»

Metavention raises $65m to tackle diabetes with metabolic ...

Jan 9, 2018ย ยท Abnormally high blood glucose levels in people with diabetes have been associated with an overactive sympathetic nervous system, according to Metavention. The Minneapolis โ€ฆSee details»

Metavention Company Profile: Overview and Full News Analysis

Metavention is dedicated to developing groundbreaking treatments for high blood pressure and metabolic diseases. Their iRF Denervation System offers a minimally invasive procedure for โ€ฆSee details»

Blog - Metavention

Feb 24, 2017ย ยท Metaventionโ€™s Renal Denervation Pivotal IDE Study now Approved by FDA for the Treatment of Hypertension. Jun 21, 2023; Read MoreSee details»

Metavention - Funding, Financials, Valuation & Investors

Metavention develops medical devices to help with interventional therapies for high blood pressure and other metabolic diseases.See details»

Metavention Completes U.S. Enrollment in Groundbreaking โ€ฆ

MINNEAPOLIS, Jan. 5, 2022 /PRNewswire/ -- Metavention, Inc. announces the completion of enrollment in the DeLIVER U.S. Study (NCT04285554), to evaluate the safety of sympathetic โ€ฆSee details»

Early Feasibility of the Metavention Integrated Radio Frequency โ€ฆ

Sep 26, 2019ย ยท TCTMD ยฎ is produced by the Cardiovascular Research Foundation ยฎ (CRF). CRF ยฎ is committed to igniting the next wave of innovation in research and education that will help โ€ฆSee details»

linkstock.net © 2022. All rights reserved